Norges Bank Neurocrine Biosciences Inc Transaction History

Norges Bank

  • $716 Trillion
  • Q3 2024

Shares

48 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$130.86 - $143.19 $58.8 Million - $64.4 Million
449,565 New
449,565 $61.9 Million
Q4 2023

Feb 09, 2024
BUY
$106.07 - $132.76 $28.8 Million - $36 Million
271,182 New
271,182 $35.7 Million
Q3 2023

Nov 13, 2024
BUY
$94.02 - $117.1 $7.51 Million - $9.36 Million
79,905 New
79,905 $8.99 Million
Q3 2023

Nov 13, 2023
SELL
$94.02 - $117.1 $82.1 Million - $102 Million
-873,673 Closed
0 $0
Q2 2023

Aug 14, 2024
SELL
$89.53 - $104.87 $35.4 Million - $41.4 Million
-395,238 Reduced 87.92%
54,327 $5.12 Million
Q2 2023

Aug 14, 2023
SELL
$89.53 - $104.87 $76.5 Million - $89.7 Million
-854,942 Closed
0 $0
Q1 2023

May 15, 2024
BUY
$94.11 - $123.02 $74.9 Million - $97.9 Million
795,410 New
795,410 $80.5 Million
Q4 2022

Feb 14, 2023
BUY
$106.72 - $127.06 $99.9 Million - $119 Million
935,915 New
935,915 $112 Million
Q3 2022

Nov 13, 2023
BUY
$92.03 - $107.81 $80.4 Million - $94.2 Million
873,673 New
873,673 $92.8 Million
Q2 2022

Aug 14, 2023
BUY
$75.79 - $100.07 $64.8 Million - $85.6 Million
854,942 New
854,942 $83.3 Million
Q1 2022

May 12, 2023
SELL
$72.45 - $94.81 $7.6 Million - $9.94 Million
-104,856 Reduced 11.2%
831,059 $77.9 Million
Q1 2022

May 09, 2022
SELL
$72.45 - $94.81 $55.7 Million - $72.9 Million
-768,416 Closed
0 $0
Q4 2021

Mar 09, 2022
BUY
$79.65 - $106.22 $61.2 Million - $81.6 Million
768,416 New
768,416 $65.4 Million
Q3 2021

Nov 14, 2022
BUY
$86.18 - $99.03 $65.9 Million - $75.7 Million
764,419 New
764,419 $73.3 Million
Q3 2021

Nov 05, 2021
SELL
$86.18 - $99.03 $63.2 Million - $72.6 Million
-733,202 Closed
0 $0
Q2 2021

Aug 15, 2022
BUY
$89.43 - $102.27 $65.6 Million - $75 Million
733,202 New
733,202 $71.4 Million
Q2 2021

Aug 10, 2021
SELL
$89.43 - $102.27 $61.3 Million - $70.1 Million
-685,602 Closed
0 $0
Q1 2021

May 09, 2022
BUY
$87.57 - $119.4 $60 Million - $81.9 Million
685,602 New
685,602 $66.7 Million
Q1 2021

May 07, 2021
SELL
$87.57 - $119.4 $61.9 Million - $84.5 Million
-707,402 Closed
0 $0
Q4 2020

Mar 02, 2021
BUY
$86.91 - $108.33 $61.5 Million - $76.6 Million
707,402 New
707,402 $67.8 Million
Q4 2020

Feb 10, 2021
SELL
$86.91 - $108.33 $64.3 Million - $80.1 Million
-739,351 Closed
0 $0
Q3 2020

Nov 12, 2021
BUY
$96.16 - $135.15 $71.1 Million - $99.9 Million
739,351 New
739,351 $71.1 Million
Q3 2020

Nov 10, 2020
SELL
$96.16 - $135.15 $72.4 Million - $102 Million
-752,551 Closed
0 $0
Q2 2020

Aug 13, 2021
BUY
$85.09 - $130.36 $64 Million - $98.1 Million
752,551 New
752,551 $91.8 Million
Q2 2020

Aug 07, 2020
SELL
$85.09 - $130.36 $67.3 Million - $103 Million
-790,835 Closed
0 $0
Q1 2020

May 07, 2021
BUY
$75.11 - $113.76 $59.4 Million - $90 Million
790,835 New
790,835 $68.4 Million
Q1 2020

May 08, 2020
SELL
$75.11 - $113.76 $59 Million - $89.4 Million
-785,914 Closed
0 $0
Q4 2019

Mar 03, 2020
BUY
$86.8 - $118.57 $68.2 Million - $93.2 Million
785,914 New
785,914 $84.5 Million
Q4 2019

Feb 12, 2020
SELL
$86.8 - $118.57 $74.4 Million - $102 Million
-856,611 Closed
0 $0
Q3 2019

Nov 13, 2020
BUY
$83.82 - $101.5 $71.8 Million - $86.9 Million
856,611 New
856,611 $77.2 Million
Q3 2019

Nov 08, 2019
SELL
$83.82 - $101.5 $71.8 Million - $86.9 Million
-856,611 Closed
0 $0
Q2 2019

Aug 13, 2020
BUY
$72.24 - $91.27 $61.9 Million - $78.2 Million
856,611 New
856,611 $72.3 Million
Q2 2019

Aug 09, 2019
SELL
$72.24 - $91.27 $61.9 Million - $78.2 Million
-856,611 Closed
0 $0
Q4 2018

Mar 04, 2019
BUY
$68.32 - $124.36 $58.5 Million - $107 Million
856,611 New
856,611 $61.2 Million
Q4 2018

Feb 08, 2019
SELL
$68.32 - $124.36 $58.5 Million - $107 Million
-856,611 Closed
0 $0
Q3 2018

Nov 12, 2019
BUY
$98.88 - $125.85 $84.7 Million - $108 Million
856,611 New
856,611 $105 Million
Q3 2018

Nov 09, 2018
SELL
$98.88 - $125.85 $84.7 Million - $108 Million
-856,611 Closed
0 $0
Q2 2018

Aug 12, 2019
BUY
$75.3 - $105.99 $64.5 Million - $90.8 Million
856,611 New
856,611 $84.2 Million
Q2 2018

Jul 23, 2018
SELL
$75.3 - $105.99 $66 Million - $92.9 Million
-876,268 Closed
0 $0
Q1 2018

May 15, 2019
BUY
$75.88 - $92.43 $66.5 Million - $81 Million
876,268 New
876,268 $72.7 Million
Q1 2018

May 09, 2018
SELL
$75.88 - $92.43 $66.5 Million - $81 Million
-876,268 Closed
0 $0
Q4 2017

Mar 05, 2018
BUY
$58.53 - $77.59 $51.3 Million - $68 Million
876,268 New
876,268 $68 Million
Q4 2017

Feb 09, 2018
SELL
$58.53 - $77.59 $51.3 Million - $68 Million
-876,268 Closed
0 $0
Q3 2017

Nov 13, 2018
BUY
$47.97 - $61.28 $42 Million - $53.7 Million
876,268 New
876,268 $53.7 Million
Q3 2017

Nov 07, 2017
SELL
$47.97 - $61.28 $42 Million - $53.7 Million
-876,268 Closed
0 $0
Q2 2017

Jul 24, 2018
BUY
N/A
80,974 Added 10.18%
876,268 $40.3 Million
Q1 2017

May 11, 2018
SELL
N/A
-103,360 Reduced 11.5%
795,294 $34.4 Million
Q3 2016

Nov 13, 2017
BUY
N/A
898,654
898,654 $0

Others Institutions Holding NBIX

# of Institutions
629
Shares Held
94.2M
Call Options Held
692K
Put Options Held
406K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $12B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email